All One Health Content – Page 10
-
NewsResearchers test new, more reliable method to detect chagas disease
Researchers have successfully tested a faster, more sensitive and reliable way to diagnose Chagas disease, a debilitating parasitic illness that affects approximately 6 million people worldwide.
-
NewsMcMaster leads Canada’s first-ever guidelines for Post COVID-19 Condition
A team of experts from McMaster University has led the creation of Canada’s first-ever comprehensive guidelines for diagnosing, managing, preventing, and treating post COVID-19 condition (PCC), more commonly known as long COVID.
-
NewsFour advances that could change tuberculosis treatment
World Tuberculosis Day commemorates Robert Koch’s discovery of the source bacterium Mycobacterium tuberculosis. Scientists are still refining TB diagnosis methods and treatment strategies - some of the latest innovations are revealed here.
-
NewsTuberculosis in children and adolescents: EU/EEA observes a rise in 2023
The notification rate of tuberculosis (TB) went up from 2 to 2.5 per 100,000 population. But overall, numbers of notified paediatric cases remain relatively low across the region.
-
NewsEfficacy of topical Nigella sativa L. with vinegar in the treatment of acne vulgaris
A team of researchers in India assessed the efficacy and safety of a topical formulation combining Kalonji and Sirka for the treatment of mild to moderate acne vulgaris. The formulation was compared with a 5% benzoyl peroxide.
-
NewsJapanese plant Daphne pseudomezereum yields anti-HIV daphnane diterpenoids
Scientists have discovered for the first time that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting replication of human immunodeficiency virus (HIV).
-
NewsDeadly bacteria developed the ability to produce antimicrobials and wiped-out competitors
A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an antimicrobial genetic tool, eliminating its cousins and replacing them as the dominant strain.
-
NewsWHO calls for urgent action to address worldwide disruptions in tuberculosis services
Since World Tuberculosis Day is only days away, World Health Organization addresses the current challenges faced by countries in TB responses. They urgently call for an united global effort to combat the deadly disease and safeguard the public health from the devastating consequences.
-
NewsH5N1 influenza viral lineages beginning to evade human immunological defenses
A new computer modelling approach predicts the protein-antibody interactions of the potentially pandemic-causing H5N1 avian influenza virus lineage. It helps to understand the viral evolution to ensure high vaccine efficacy.
-
NewsUpdated guidelines for pediatric Mycoplasma pneumoniae infection
In light of the rise in antibiotic resistance, new guidelines are released with detailed recommendations of diagnosis and treatment strategies for pediatric Mycoplasma pneumoniae pneumonia (MPP), along with the means to manage severe complications.
-
NewsHidden threat: The evolving fungus that spreads through cats and humans
Researchers have developed a better understanding about the molecular basis of the Sporothrix species in virulence and evolution, amid the largest sporotrichosis epidemic in Brazil. The identification of the genetic markers helps to enhance fungal surveillance and strengthen disease control.
-
NewsLong COVID could be causing huge economic burden annually
Behind the healthcare burden from long COVID, a study has also uncovered the economic burden of those who are more likely to suffer from long COVID through a computer simulation model of long COVID probabilities and the accompanied productivity loss.
-
NewsResearchers discover Achilles heel of Lyme disease pathogen
Researchers discovered and investigated an unique enzyme used in the pathway specific to Borrelia burgdorferi, the parasite that causes Lyme disease. The enzyme serves as the ideal genus-specific target for therapeutic intervention.
-
NewsNew study reveals high levels of fusarium mycotoxins in seized cannabis from Arizona and California
A recent study has uncovered alarming levels of Fusarium mycotoxins in illicit cannabis samples seized in Arizona and California. 16% of the 118 samples tested positive for harmful mycotoxins, posing potential health risks to consumers and highlighting the unregulated and dangerous nature of black-market cannabis.
-
NewsTeam finds regional, age-related trends in exposure to drug-resistant pathogen
A study from 10 US states found drug-resistant Campylobacter jejuni infections were highest in the 20-39 age group and that quinolone-resistant C. jejuni infections increased from 22.6% of those tested in 2013 to 33.54% in 2019. It identified regional differences in C. jejuni resistance to quinolones and six other classes of antibiotics.
-
NewsStudy yields new data on Mpox vaccine effectiveness in people with HIV
A new study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, especially people with HIV, should receive the second dose of the vaccine as recommended.
-
NewsHost’s sex plays key role in how gut microbiome evolves with age
Researchers studied how aging affects gut bacteria in a special group of rats generated to have genetic diversity similar to humans. Their research found that both biological sex and mitochondrial DNA—the small set of genes inherited only from mothers—play a key role in how gut bacteria change over time.
-
NewsLead science organizations affirm vaccine safety amid rising misinformation and declining trust
A unified statement, issued by a coalition of leading scientific and medical organizations, addresses the rise in vaccine misinformation and a decline in trust of science, amidst the outbreaks of preventible infectious diseases. It reassures the current concerns on vaccine safety and emphasizes the importance of vaccinations in public health.
-
NewsFDA-approved dialysis drug may help fight against antimicrobial resistance
In account of the imminent threat of antimicrobial resistance (AMR), a study revealed that the FDA-approved sevelamer, which is used to treat chronic kidney disease undergoing dialysis, is successful in the removal of other off-target antibiotics (vancomycin and daptomycin) from the gut.
-
NewsProfessor Sabiha Essack wins Christiana Figueres Policy to Practice Award
Professor Sabiha Essack, the South African Research Chair in Antibiotic Resistance and One Health, Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal, has been awarded the Christiana Figueres Policy to Practice Award.